Literature DB >> 32104572

An Interaction Between Glecaprevir, Pibrentasvir, and Colchicine Causing Rhabdomyolysis in a Patient With Chronic Renal Disease.

Dawn S Harrison1, Jane Giang2, Jama M Darling1.   

Abstract

Entities:  

Year:  2020        PMID： 32104572      PMCID： PMC7041960          DOI： 10.1002/cld.833

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  11 in total

1.  Fibroscan (transient elastography) for the measurement of liver fibrosis.

Authors:  Nezam H Afdhal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-09

Review 2.  Rhabdomyolysis.

Authors:  Janice L Zimmerman; Michael C Shen
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

3.  The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions.

Authors:  Elise J Smolders; Floor Ac Berden; Clara Tmm de Kanter; Wietske Kievit; Joost Ph Drenth; David M Burger
Journal:  United European Gastroenterol J       Date:  2016-11-04       Impact factor: 4.623

4.  Economic model of a birth cohort screening program for hepatitis C virus.

Authors:  Lisa J McGarry; Vivek S Pawar; Hemangi R Panchmatia; Jaime L Rubin; Gary L Davis; Zobair M Younossi; James C Capretta; Michael J O'Grady; Milton C Weinstein
Journal:  Hepatology       Date:  2012-03-18       Impact factor: 17.425

Review 5.  Rhabdomyolysis.

Authors:  John M Sauret; George Marinides; Gordon K Wang
Journal:  Am Fam Physician       Date:  2002-03-01       Impact factor: 3.292

6.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

7.  Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

Authors:  Edward Gane; Eric Lawitz; David Pugatch; Georgios Papatheodoridis; Norbert Bräu; Ashley Brown; Stanislas Pol; Vincent Leroy; Marcello Persico; Christophe Moreno; Massimo Colombo; Eric M Yoshida; David R Nelson; Christine Collins; Yang Lei; Matthew Kosloski; Federico J Mensa
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

8.  An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function.

Authors:  Shyam Patel; Jennifer Andres; Kamran Qureshi
Journal:  Case Rep Med       Date:  2016-08-22

9.  Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Authors:  David Roth; David R Nelson; Annette Bruchfeld; AnnMarie Liapakis; Marcelo Silva; Howard Monsour; Paul Martin; Stanislas Pol; Maria-Carlota Londoño; Tarek Hassanein; Philippe J Zamor; Eli Zuckerman; Shuyan Wan; Beth Jackson; Bach-Yen Nguyen; Michael Robertson; Eliav Barr; Janice Wahl; Wayne Greaves
Journal:  Lancet       Date:  2015-10-05       Impact factor: 202.731

10.  Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.

Authors:  Francisca Sivera; Mariano Andrés; Loreto Carmona; Alison S R Kydd; John Moi; Rakhi Seth; Melonie Sriranganathan; Caroline van Durme; Irene van Echteld; Ophir Vinik; Mihir D Wechalekar; Daniel Aletaha; Claire Bombardier; Rachelle Buchbinder; Christopher J Edwards; Robert B Landewé; Johannes W Bijlsma; Jaime C Branco; Rubén Burgos-Vargas; Anca I Catrina; Dirk Elewaut; Antonio J L Ferrari; Patrick Kiely; Burkhard F Leeb; Carlomaurizio Montecucco; Ulf Müller-Ladner; Mikkel Ostergaard; Jane Zochling; Louise Falzon; Désirée M van der Heijde
Journal:  Ann Rheum Dis       Date:  2013-07-18       Impact factor: 19.103
View more
  1 in total

1.  Revolution in the diagnosis and management of hepatitis C virus infection in current era.

Authors:  Farina M Hanif; Zain Majid; Nasir Hassan Luck; Abbas Ali Tasneem; Syed Muddasir Laeeq; Muhammed Mubarak
Journal:  World J Hepatol       Date:  2022-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.